Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 5, 2025, 12:18 PM EDT
Nutra Pharma Revenue
In the year 2022, Nutra Pharma had annual revenue of $438.27K with 348.43% growth. Nutra Pharma had revenue of $109.20K in the quarter ending September 30, 2022, with 466.82% growth.
Revenue
438.27K
Revenue Growth
+348.43%
P/S Ratio
1.62
Revenue / Employee
109.57K
Employees
6
Market Cap
709.97K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 438.27K | 340.54K | 348.43% |
Dec 31, 2021 | 97.74K | 45.84K | 88.32% |
Dec 31, 2020 | 51.90K | -52.50K | -50.29% |
Dec 31, 2019 | 104.39K | -26.20K | -20.06% |
Dec 31, 2018 | 130.60K | 9.62K | 7.95% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |